Published in J Gen Virol on November 01, 1999
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol (2003) 4.45
Recombinant Newcastle disease virus as a vaccine vector. J Virol (2001) 2.67
Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A (2006) 2.23
Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci U S A (2006) 1.58
A recombinant newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. J Virol (2001) 1.40
Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. Mol Ther (2009) 1.18
Virulence of Newcastle disease virus: what is known so far? Vet Res (2011) 1.18
Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses. J Virol (2008) 1.17
Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope. J Virol (2002) 1.00
Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens. J Virol (2011) 0.96
Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 2 increase cleavability and syncytium formation but do not increase viral virulence in chickens. J Virol (2011) 0.92
Expression of transgenes from newcastle disease virus with a segmented genome. J Virol (2008) 0.90
Characterization of a recombinant Newcastle disease virus vaccine strain. Clin Vaccine Immunol (2008) 0.89
Novel approaches to develop Rift Valley fever vaccines. Front Cell Infect Microbiol (2012) 0.88
Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection. Philos Trans R Soc Lond B Biol Sci (2001) 0.87
Chimeric newcastle disease virus protects chickens against avian influenza in the presence of maternally derived NDV immunity. PLoS One (2013) 0.86
Virus-vectored influenza virus vaccines. Viruses (2014) 0.86
Artificial recombination may influence the evolutionary analysis of Newcastle disease virus. J Virol (2011) 0.86
Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics. Virology (2015) 0.83
Different regions of the newcastle disease virus fusion protein modulate pathogenicity. PLoS One (2014) 0.83
Detection of free peritoneal cancer cells in gastric cancer using cancer-specific Newcastle disease virus. J Gastrointest Surg (2009) 0.78
An overview on the development of newcastle disease virus as an anti-cancer therapy. Malays J Med Sci (2003) 0.78
Rescue of recombinant Newcastle disease virus from cDNA. J Vis Exp (2013) 0.78
Hybrid- and complex-type N-glycans are not essential for Newcastle disease virus infection and fusion of host cells. Glycobiology (2011) 0.77
Effects of naturally occurring six- and twelve-nucleotide inserts on Newcastle disease virus replication and pathogenesis. PLoS One (2014) 0.77
Rescue of virulent class I Newcastle disease virus variant 9a5b-D5C1. Virol J (2012) 0.75
Efficient and Robust Paramyxoviridae Reverse Genetics Systems. mSphere (2017) 0.75
Applications of Replicating-Competent Reporter-Expressing Viruses in Diagnostic and Molecular Virology. Viruses (2016) 0.75
Viral vector vaccines expressing nucleoprotein and phosphoprotein genes of avian bornaviruses ameliorate homologous challenge infections in cockatiels and common canaries. Sci Rep (2016) 0.75
Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines. Clin Exp Vaccine Res (2017) 0.75
Infectious rabies viruses from cloned cDNA. EMBO J (1994) 8.35
Ultrastructural analysis of the replication cycle of pseudorabies virus in cell culture: a reassessment. J Virol (1997) 3.29
Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol (1991) 3.00
Egress of alphaherpesviruses: comparative ultrastructural study. J Virol (2001) 2.92
Primary envelopment of pseudorabies virus at the nuclear membrane requires the UL34 gene product. J Virol (2000) 2.91
Pseudorabies virus avirulent strains fail to express a major glycoprotein. J Virol (1985) 2.70
Inhibition of virion maturation by simultaneous deletion of glycoproteins E, I, and M of pseudorabies virus. J Virol (1999) 2.52
Complex between glycoproteins gI and gp63 of pseudorabies virus: its effect on virus replication. J Virol (1988) 2.24
Effect of the pseudorabies virus US3 protein on nuclear membrane localization of the UL34 protein and virus egress from the nucleus. J Gen Virol (2001) 2.23
Role of the cytoplasmic tail of pseudorabies virus glycoprotein E in virion formation. J Virol (2000) 2.17
Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex. J Virol (1985) 2.14
Role of pseudorabies virus glycoprotein gI in virus release from infected cells. J Virol (1987) 2.11
Glycoprotein gIII of pseudorabies virus is multifunctional. J Virol (1988) 2.05
Pseudorabies virus UL37 gene product is involved in secondary envelopment. J Virol (2001) 2.01
Pseudorabies virus glycoprotein M inhibits membrane fusion. J Virol (2000) 1.94
Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science (1995) 1.93
Glycoproteins M and N of pseudorabies virus form a disulfide-linked complex. J Virol (1998) 1.79
Mapping of the structural gene of pseudorabies virus glycoprotein A and identification of two non-glycosylated precursor polypeptides. J Virol (1985) 1.78
Role of envelope glycoproteins gI, gp63 and gIII in the invasion and spread of Aujeszky's disease virus in the olfactory nervous pathway of the pig. J Gen Virol (1994) 1.73
Deletion of glycoprotein gE reduces the propagation of pseudorabies virus in the nervous system of mice after intranasal inoculation. Virology (1996) 1.72
Glycoproteins gIII and gp50 play dominant roles in the biphasic attachment of pseudorabies virus. Virology (1993) 1.72
Glycoprotein gL-independent infectivity of pseudorabies virus is mediated by a gD-gH fusion protein. J Virol (1999) 1.70
Pathology of natural infections by H5N1 highly pathogenic avian influenza virus in mute (Cygnus olor) and whooper (Cygnus cygnus) swans. Vet Pathol (2007) 1.70
Effects of truncation of the carboxy terminus of pseudorabies virus glycoprotein B on infectivity. J Virol (2000) 1.67
Identification and characterization of the pseudorabies virus UL3.5 protein, which is involved in virus egress. J Virol (1996) 1.66
Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1. J Virol (1991) 1.64
Pseudorabies virus glycoprotein L is necessary for virus infectivity but dispensable for virion localization of glycoprotein H. J Virol (1997) 1.59
A non-canonical lon proteinase lacking the ATPase domain employs the ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus. EMBO J (2000) 1.58
The UL20 gene product of pseudorabies virus functions in virus egress. J Virol (1997) 1.52
Pseudorabies virus glycoprotein K requires the UL20 gene product for processing. J Virol (2000) 1.49
Identification and characterization of pseudorabies virus glycoprotein gM as a nonessential virion component. J Virol (1996) 1.48
Pseudorabies virus glycoprotein gK is a virion structural component involved in virus release but is not required for entry. J Virol (1998) 1.44
Sequence and expression of the glycoprotein gH gene of pseudorabies virus. Virology (1991) 1.43
Role of essential glycoproteins gII and gp50 in transneuronal transfer of pseudorabies virus from the hypoglossal nerves of mice. J Virol (1993) 1.41
Stable rescue of a glycoprotein gII deletion mutant of pseudorabies virus by glycoprotein gI of bovine herpesvirus 1. J Virol (1992) 1.41
Glycoprotein gH of pseudorabies virus is essential for penetration and propagation in cell culture and in the nervous system of mice. J Gen Virol (1996) 1.39
Green fluorescent protein expressed by recombinant pseudorabies virus as an in vivo marker for viral replication. J Virol Methods (1997) 1.38
Mutations affecting the UL21 gene contribute to avirulence of pseudorabies virus vaccine strain Bartha. Virology (1995) 1.38
Glycoprotein IV of bovine herpesvirus 1-expressing cell line complements and rescues a conditionally lethal viral mutant. J Virol (1992) 1.37
Epidemiological and ornithological aspects of outbreaks of highly pathogenic avian influenza virus H5N1 of Asian lineage in wild birds in Germany, 2006 and 2007. Transbound Emerg Dis (2009) 1.37
Identification and characterization of a novel structural glycoprotein in pseudorabies virus, gL. J Virol (1994) 1.36
The UL49.5 gene of pseudorabies virus codes for an O-glycosylated structural protein of the viral envelope. J Virol (1996) 1.36
Pseudorabies virus in wild swine: a global perspective. Arch Virol (2011) 1.33
Location of the structural gene of pseudorabies virus glycoprotein complex gII. Virology (1986) 1.32
Synaptic and neurotransmitter activation of cardiac vagal neurons in the nucleus ambiguus. Ann N Y Acad Sci (2001) 1.32
Propagation of pseudorabies virus in the nervous system of the mouse after intranasal inoculation. Virology (1994) 1.30
Rapid molecular subtyping by reverse transcription polymerase chain reaction of the neuraminidase gene of avian influenza A viruses. Vet Microbiol (2008) 1.29
Pseudorabies virus and equine herpesvirus 1 share a nonessential gene which is absent in other herpesviruses and located adjacent to a highly conserved gene cluster. J Virol (1995) 1.28
Herpesvirus (pseudorabies virus) latency in swine: occurrence and physical state of viral DNA in neural tissues. Virology (1986) 1.26
Identification and characterization of pseudorabies virus glycoprotein H. J Virol (1992) 1.26
Alteration of amino acids in VP2 of very virulent infectious bursal disease virus results in tissue culture adaptation and attenuation in chickens. J Gen Virol (2002) 1.26
Adaptability in herpesviruses: glycoprotein D-independent infectivity of pseudorabies virus. J Virol (1997) 1.24
Invasion and spread of single glycoprotein deleted mutants of Aujeszky's disease virus (ADV) in the trigeminal nervous pathway of pigs after intranasal inoculation. Vet Microbiol (1994) 1.22
Distribution of lesions and antigen of highly pathogenic avian influenza virus A/Swan/Germany/R65/06 (H5N1) in domestic cats after presumptive infection by wild birds. Vet Pathol (2007) 1.21
Intracellular processing of pseudorabies virus glycoprotein M (gM): gM of strain Bartha lacks N-glycosylation. Virology (1997) 1.20
Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine. J Virol (1993) 1.20
Suprachiasmatic nucleus: a central autonomic clock. Nat Neurosci (1999) 1.20
Release of pseudorabies virus from infected cells is controlled by several viral functions and is modulated by cellular components. J Virol (1989) 1.17
Cell surface proteoglycans are not essential for infection by pseudorabies virus. J Virol (1995) 1.17
Deletion of glycoprotein gM of pseudorabies virus results in attenuation for the natural host. J Gen Virol (1997) 1.14
Encephalitis in a stone marten (Martes foina) after natural infection with highly pathogenic avian influenza virus subtype H5N1. J Comp Pathol (2007) 1.13
DNA sequence and transcriptional analysis of the UL1 to UL5 gene cluster of infectious laryngotracheitis virus. J Gen Virol (1996) 1.13
Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin. J Gen Virol (2001) 1.12
DNA sequence of the UL6 to UL20 genes of infectious laryngotracheitis virus and characterization of the UL10 gene product as a nonglycosylated and nonessential virion protein. J Gen Virol (1999) 1.10
Establishment of a competitive ELISA (cELISA) system for the detection of influenza A virus nucleoprotein antibodies and its application to field sera from different species. J Vet Med B Infect Dis Vet Public Health (2006) 1.10
Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes. J Gen Virol (1990) 1.10
CNS inputs to the suprachiasmatic nucleus of the rat. Neuroscience (2002) 1.08
Protection of pigs against Aujeszky's disease by DNA vaccination. J Gen Virol (1997) 1.08
Eradication of Aujeszky's disease in Germany. J Vet Med B Infect Dis Vet Public Health (2003) 1.08
Identification and characterization of pseudorabies virus dUTPase. J Virol (1996) 1.07
A second form of infectious bursal disease virus-associated tubule contains VP4. J Virol (1997) 1.07
Complete genomic sequence of the fish rhabdovirus infectious haematopoietic necrosis virus. J Gen Virol (1995) 1.06
Neurotropism of highly pathogenic avian influenza virus A/chicken/Indonesia/2003 (H5N1) in experimentally infected pigeons (Columbia livia f. domestica). Vet Pathol (2006) 1.06
Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes. J Virol (1990) 1.06
Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells. J Virol (1997) 1.05
Firefly luciferase as a marker for herpesvirus (pseudorabies virus) replication in vitro and in vivo. J Gen Virol (1991) 1.04
Single CNS neurons link both central motor and cardiosympathetic systems: a double-virus tracing study. Neuroscience (2003) 1.04
CNS cell groups projecting to the submandibular parasympathetic preganglionic neurons in the rat: a retrograde transneuronal viral cell body labeling study. Brain Res (1992) 1.03
Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus. J Virol (1994) 1.03
Role of the cytoplasmic tails of pseudorabies virus glycoproteins B, E and M in intracellular localization and virion incorporation. J Gen Virol (2001) 1.02
Complete genomic sequence of viral hemorrhagic septicemia virus, a fish rhabdovirus. Virus Genes (1999) 1.02
Fish rhabdoviruses: molecular epidemiology and evolution. Curr Top Microbiol Immunol (2005) 1.02
Variability of pseudorabies virus glycoprotein I expression. Virology (1987) 1.01
Activity of cardiorespiratory networks revealed by transsynaptic virus expressing GFP. J Neurophysiol (2001) 1.00
Infectivity of a pseudorabies virus mutant lacking attachment glycoproteins C and D. J Virol (1998) 1.00
Potency of an experimental DNA vaccine against Aujeszky's disease in pigs. Vet Microbiol (1999) 0.99
Pseudorabies virus displays variable numbers of a repeat unit adjacent to the 3' end of the glycoprotein gII gene. J Gen Virol (1989) 0.98
beta-Galactosidase expressing recombinant pseudorabies virus for light and electron microscopic study of transneuronally labeled CNS neurons. Brain Res (1991) 0.96
Emergence of a novel cluster of influenza A(H5N1) virus clade 2.2.1.2 with putative human health impact in Egypt, 2014/15. Euro Surveill (2015) 0.96
Comparison of the genomes of 15 avian herpes-virus isolates by restriction endonuclease analysis. Avian Pathol (1997) 0.95
Infection of Chinese hamster ovary cells by pseudorabies virus. J Virol (1999) 0.95
Identification and transcriptional analysis of pseudorabies virus UL6 to UL12 genes. Arch Virol (1997) 0.95
Unidirectional complementation between glycoprotein B homologues of pseudorabies virus and bovine herpesvirus 1 is determined by the carboxy-terminal part of the molecule. J Gen Virol (1995) 0.94
Antibody-induced endocytosis of viral glycoproteins and major histocompatibility complex class I on pseudorabies virus-infected monocytes. J Gen Virol (1999) 0.94